공복혈당수치와 운동유발전위의 상관관계에 대한 후향적 분석
A Retrospective Study on the Correlation between Fasting Blood Sugar and Motor Evoked Potentials : Comparison between Central and Peripheral Motor Nerve
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Objectives : Peripheral neurodegeneration occurs in diabetes mellitus (DM), both sensory and motor nerve, but we don't know exactly if DM affects central nerve pathway for all studies. Electrophysiologic study is one of the most important diagnostic tools for diabetic neuropathy. Electroneurography and electromyography are usually used, but evoked potentials (EP) is more sensitive to small nerve fiber damages and useful for central nerve evaluation in addition to peripheral nerves. Most diabetic neuropathy studies by EP have been performed with somatosensory evoked potentials (SSEP). In contrast, the objective of this study is to investigate if DM targets central motor neurons by assessing the relation between fasting blood sugar (FBS) and motor evoked potentials (MEP) latency.Methods : We inspected the medical records of 34 patients who had MEP tests during admitting days. The latency from cervical portion to abductor pollicis brevis was used as peripheral motor conduction time (PMCT), and the latency from vertex to cervical portion was used as central motor conduction time (CMCT). Then, they were correlated to FBS using correlation analysis. Results : There was a significant linear relation between FBS and PMCT (Pearson’s correlation coefficient r=0.487, p<0.01), but a poor linear relation between FBS and CMCT (Pearson’s correlation coefficient r=-0.197, p>0.05).Conclusions : This study suggests that prolonged latencies of MEP in DM may be due to peripheral neuropathy rather than dysfunction of central motor pathway, therefore the clinical use of MEP to diabetic neuropathy has to be divided segmentally.
참고문헌 (17)
- Moon JS, "Serial follow -ups of nerve conduction studies in diabetic patients", 15, pp.309~318 (1997)
- 이지현, "당뇨병성 말초신경병증의 선별검사 및 진단의 실제", pp.189~195 (2006)
- Boulton AJM,, "Diabetic neuropathies. A statement by the American Diabetes Association", 28, pp.956~962 (2005)
- Kim DS, "The somatosensory evoked potentials and nerve conduction studies in patients with diabetic polyneuropathy", 20, pp.49~53 (2002)
- "Spinal somatosensory evoked potentials in juvenile diabetes", 15, pp.55~8 (1984)
- "Spinal somatosensory conduction in diabetes", 31, pp.841~5 (1981)
- "Does diabetes mellitus target motor neurons", 26, pp.301~311 (2007)
- "Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ)", 285, pp.2486~2497 (2001)
- "Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus", 20, pp.1183~1197 (1997), American Diabetes Association
- "Diabetic myelopathy", 102, pp.467~9 (1978)
- "Peripheral and central conduction abnormalities in diabetes mellitus", 54, pp.1932~1937 (2000)
- "Clinical utility of somatosensory evoked potentials in diabetes mellitus", 7, pp.17~23 (1989)
- "Does diabetes mellitus target motor neurons?", 26, pp.301~311 (2007)
- "Muscle contractility decrement and correlated morphology during the pathogenesis of streptozotocin-diabetic mice", 251, pp.240~244 (1998)
- "The influence of indomethacin and guanethidine on experimental streptozotocin diabetic neuropathy", 19, pp.433~41 (1992)
- "Magnetic motor evoked potential in non-insulin dependent diabetic patients", pp.270~8 (1994)
- "Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000", 112, pp.331~338 (2004)
